Cart
sales@molnova.com
Ot-730
CAS No. 870809-51-1
Ot-730( —— )
Catalog No. M36208 CAS No. 870809-51-1
Ot-730（QLT 091568）is a novel selective beta-blocker prodrug for the study of ocular diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 459 | In Stock |
|
| 10MG | 657 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOt-730
-
NoteResearch use only, not for human use.
-
Brief DescriptionOt-730（QLT 091568）is a novel selective beta-blocker prodrug for the study of ocular diseases.
-
DescriptionOt-730（QLT 091568）is a novel selective beta-blocker prodrug for the study of ocular diseases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number870809-51-1
-
Formula Weight492.56
-
Molecular FormulaC25H36N2O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(O[C@@H](CNC(CNC(=O)C1CCOC1)(C)C)COC(=O)C2=C(C)C=C(O)C(O)=C2)(=O)C3(C)CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
1-Methylindazole-3-c...
It is an excellent solvent with proper boiling point.
-
Polatuzumab
Polatuzumab is a monoclonal antibody that targets CD79b and carries chemotherapeutically active molecules.Polatuzumab adheres to CD79b proteins and transports the chemotherapeutically active molecules into cells to kill them.
-
t-OMe-Byakangelicin
(R)-tert-OMe-byakangelicin is a kind of furanocoumarin, which has inhibitory activity to liver drug metabolizing enzyme (DME) activity. (R)-tert-OMe-byakangelicin can be isolated from immature fruits of Angelica sinensis.
